This site requires javascript. Please turn that on in your browser\'s preferences. How?

Axis Neuromonitoring Axis Neuromonitoring

AXIS Neuromonitoring provides high quality intraoperative neurophysiological monitoring (IONM). During surgery, we monitor the integrity of nerves and neurological responses along neural pathways, helping surgeons identify and protect neural structures.

Neuromonitoring 101

If your surgeon has requested neuromonitoring for your upcoming procedure, you may have questions. Find out what neuromonitoring is and how it benefits your surgery.

Will My Insurance Cover IONM?

There are many different insurance policies with varying coverages. So we’ll help you find out if yours covers IONM. Here’s what you can do to help make the process easier.

Time for Q&A

You don’t have to be an expert in neuromonitoring—that’s our job. However, we have provided some of our most commonly asked questions and their answers for you to read.

The Day of Surgery

To help prepare our patients for their upcoming surgeries, we created this short video. It illustrates the role AXIS Neuromonitoring plays the day of surgery.

Learn More

Latest News

03.30.20
Surgical approach linked to risk in hip replacement

The researchers say that the anterior approach to hip arthroplasty is slightly more risky than the posterior or lateral approaches. "The small but statistically significant increase in the risk of major surgical complications associated with the anterior approach may help inform decisions for total hip arthroplasty," write Daniel Pincus, MD, PhD, of the Sunnybrook Health Sciences Center in Toronto, Canada, and his colleagues.

03.27.20
Minimally Invasive Artificial Disc Replacement Shows “Significantly Better Results” Compared to Traditional Procedures (Source: Minimally Invasive Neurosurgery of Texas)

Dr. Scott Kutz, an expert in the field of cervical spine surgery, has published a new article that discusses how minimally invasive spine surgery has shown “significantly better results” in terms of risks and recovery period than traditional open spine surgery.

03.23.20
NorthShore neurosurgeon first in Illinois to offer new targeted therapy for brain tumors

NorthShore University HealthSystem (NorthShore) neurosurgeon, Julian Bailes, MD, is the first in Illinois to begin offering GammaTile® Therapy, a new approach to treating malignant brain tumors. The FDA-cleared, Surgically Targeted Radiation Therapy (STaRT) is designed to delay tumor regrowth for patients with high grade gliomas, meningiomas and brain metastases. The first patient in the state was treated by Dr. Bailes who is chairman of the department of neurosurgery and co-director of the NorthShore Neurological Institute. Neuro-oncologist Ryan Merrell, MD, will also be participating in this new surgical therapy at NorthShore.

All News